Algernon Neuroscience Inc.
400 - 601 West Broadway
Vancouver, British Columbia, Canada V5Z 4C2
March 7, 2023
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Jimmy McNamara
Re: Algernon Neuroscience Inc.
Offering Statement on Form 1-A
File No. 024-12117
Ladies and Gentlemen:
On behalf of Algernon Neuroscience Inc. (the "Company"), I hereby request qualification of the above-referenced Offering Statement at 4:00 p.m. Eastern Time on Wednesday, March 8, 2023, or as soon thereafter as is practicable. The participant in the Company's offering received a no objections letter from FINRA on February 8, 2023.
Once the Offering Statement is qualified, please orally confirm the event with our counsel, Sheppard, Mullin, Richter & Hampton LLP, by calling Stephen Cohen at (212) 653-8166.
Sincerely,
Algernon Neuroscience Inc.
By: | /s/ Christopher J. Moreau |
Name: | Christopher J. Moreau |
Title: | Chief Executive Officer |